Aberrant human leucocyte antigen-G expression and its clinical relevance in hepatocellular carcinoma.
about
Non-classical HLA-class I expression in serous ovarian carcinoma: Correlation with the HLA-genotype, tumor infiltrating immune cells and prognosis.Significance of tumour cell HLA-G5/-G6 isoform expression in discrimination for adenocarcinoma from squamous cell carcinoma in lung cancer patients.Expression of human leukocyte antigen G is associated with prognosis in nasopharyngeal carcinoma.HLA-G expression in cancers: roles in immune evasion, metastasis and target for therapyThe immunosuppressive molecule HLA-G and its clinical implications.The Role of HLA-G Molecule and HLA-G Gene Polymorphisms in Tumors, Viral Hepatitis, and Parasitic Diseases.The Potential of HLA-G-Bearing Extracellular Vesicles as a Future Element in HLA-G Immune Biology.Cancer treatment and the KIR-HLA system: an overview.HLA-G expression is associated with metastasis and poor survival in the Balb/c nu/nu murine tumor model with ovarian cancer.Human leukocyte antigen-G is closely associated with tumor immune escape in gastric cancer by increasing local regulatory T cells.Behavior of soluble HLA-A, -B, -C and HLA-G molecules in patients with chronic hepatitis C virus infection undergoing pegylated interferon-α and ribavirin treatment: potential role as markers of response to antiviral therapy.Human leukocyte antigen-G expression is associated with a poor prognosis in patients with esophageal squamous cell carcinoma.Soluble human leukocyte antigen-G expression in hepatitis B virus infection and hepatocellular carcinoma.Evaluation of ascitic soluble human leukocyte antigen-G for distinguishing malignant ascites from benign ascites.Human leukocyte antigen-G expression and polymorphisms promote cancer development and guide cancer diagnosis/treatment.The 14bp-deletion allele in the HLA-G gene confers susceptibility to the development of hepatocellular carcinoma in the Brazilian population.Ig-like transcript 2 (ILT2) suppresses T cell function in chronic lymphocytic leukemia.Association of serum soluble human leukocyte antigen-G levels with chronic hepatitis B virus infection.Human leukocyte antigen-G (HLA-G) expression in cervical lesions: association with cancer progression, HPV 16/18 infection, and host immune response.Heterogeneity of HLA-G Expression in Cancers: Facing the ChallengesClinical Significance of Potential Unidentified HLA-G Isoforms Without α1 Domain but Containing Intron 4 in Colorectal Cancer Patients
P2860
Q30315505-6E00FB84-9174-45A6-AB06-9C8CE90F46FEQ35390989-C9564F66-8AF4-4C69-9D2C-16B73B7BD57AQ36063731-6647059D-1CE8-4AF3-850B-01D6F3F5B5E1Q36568297-0276CA4C-639F-4D95-A709-CADD4A985515Q38005743-36990EBB-1C70-45B6-87CF-B8B69D6F4C8DQ38362617-58E7448C-64E5-4B45-A590-16DB79C5276FQ38864796-123B7236-3913-4C60-A225-AABB888E273EQ39131056-BF1E8B30-90EF-4075-9590-65788A428D6BQ39486461-7149AE2D-5A49-4296-A8B6-ECDC0B30CFB1Q39564214-71222C75-E632-4A15-95C3-20530D5A220FQ40910254-FBD83623-6629-4E1F-9DB2-BD41BC5A28A1Q45061505-32169884-0DD4-4ADF-AC33-C11799DB0548Q45361327-673286D1-5A92-4E01-BBB1-86E310A1B4B8Q47410788-8AF4E664-9343-458B-B40C-07CC0659989FQ49335253-80BA6727-3446-49FA-8551-32844769CC99Q50865447-F464AF60-D4A7-4D70-8B98-BD329EC69282Q52796916-E36B5BA5-03C1-40B7-9DE0-D3AF483EA0B1Q53264084-2BD70377-0311-49DB-A63A-35E78FDCC22CQ53299358-375E583A-722A-406C-BB8A-C1DE64F848A7Q57490851-47F3D893-C2D0-4C46-A52E-2454920D2B54Q58764745-090B36C6-6565-4A82-A5D1-A9202954491B
P2860
Aberrant human leucocyte antigen-G expression and its clinical relevance in hepatocellular carcinoma.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on August 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Aberrant human leucocyte antig ...... e in hepatocellular carcinoma.
@en
Aberrant human leucocyte antig ...... e in hepatocellular carcinoma.
@nl
type
label
Aberrant human leucocyte antig ...... e in hepatocellular carcinoma.
@en
Aberrant human leucocyte antig ...... e in hepatocellular carcinoma.
@nl
prefLabel
Aberrant human leucocyte antig ...... e in hepatocellular carcinoma.
@en
Aberrant human leucocyte antig ...... e in hepatocellular carcinoma.
@nl
P2093
P2860
P1476
Aberrant human leucocyte antig ...... e in hepatocellular carcinoma.
@en
P2093
P2860
P304
P356
10.1111/J.1582-4934.2009.00917.X
P577
2010-08-01T00:00:00Z